Status: current, Primitive. Date: 30-Nov 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4252301000168117 | Mefenamic acid (MLPL) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4252311000168119 | Mefenamic acid (MLPL) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mefenamic acid (MLPL) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mefenamic acid (MLPL) 250 mg capsule, 100 | has TP | True | Mefenamic acid (MLPL) | Inferred relationship | Some | |
| Mefenamic acid (MLPL) 250 mg capsule, 30, bottle | has TP | True | Mefenamic acid (MLPL) | Inferred relationship | Some | |
| Mefenamic acid (MLPL) 250 mg capsule, 50 | has TP | True | Mefenamic acid (MLPL) | Inferred relationship | Some | |
| Mefenamic acid (MLPL) 250 mg capsule, 100, bottle | has TP | True | Mefenamic acid (MLPL) | Inferred relationship | Some | |
| Mefenamic acid (MLPL) 250 mg capsule | Is a | True | Mefenamic acid (MLPL) | Inferred relationship | Some | |
| Mefenamic acid (MLPL) 250 mg capsule, 30 | has TP | True | Mefenamic acid (MLPL) | Inferred relationship | Some | |
| Mefenamic acid (MLPL) 250 mg capsule, 50, bottle | has TP | True | Mefenamic acid (MLPL) | Inferred relationship | Some |
Reference Sets
FHIR